Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Avalo Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +29 vs. Q1 2026
- Shares held
- 70.8M
- +39.3M (+124.9%) vs. Q1 2026
- Total value
- $1.31B
- +$838.0M (+178.5%) vs. Q1 2026
- New holders
- 56
- 47 more added
- Sold out
- 27
- 15 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Trails Edge Capital Partners, LP | 891,881 | $16.5M | 2.62% | +891,881 | New |
| Goldman Sachs Group Inc | 946,320 | $17.5M | 0.00% | +886,214+1,474.4% | Added |
| Ra Capital Management, L.P. | 1,000,000 | $18.5M | 0.16% | +337,032+50.8% | Added |
| Commodore Capital LP | 1,018,319 | $18.8M | 1.12% | +535,319+110.8% | Added |
| Geode Capital Management, LLC | 1,105,118 | $20.4M | 0.00% | +935,229+550.5% | Added |
| Logos Global Management LP | 1,150,000 | $21.3M | 0.91% | +850,000+283.3% | Added |
| UBS Group AG | 1,209,059 | $22.3M | 0.00% | +67,079+5.9% | Added |
| Alliancebernstein L.P. | 1,260,689 | $23.3M | 0.01% | +1,260,689 | New |
| Price T Rowe Associates Inc | 1,311,715 | $24.2M | 0.00% | +1,311,715 | New |
| Braidwell LP | 1,629,182 | $30.1M | 1.11% | +1,629,182 | New |
| Soleus Capital Management, L.P. | 1,654,978 | $30.6M | 1.05% | +1,213,000+274.4% | Added |
| Adage Capital Partners GP, L.L.C. | 1,729,000 | $32.0M | 0.04% | +875,000+102.5% | Added |
| Nantahala Capital Management, LLC | 1,862,250 | $34.4M | 2.08% | +627,250+50.8% | Added |
| Bank of America Corp | 1,913,829 | $35.4M | 0.00% | +1,270,829+197.6% | Added |
| BVF Inc | 2,075,545 | $38.4M | 0.98% | +442,700+27.1% | Added |
| Vanguard Capital Management LLC | 2,264,246 | $41.8M | 0.00% | +1,544,552+214.6% | Added |
| Avoro Capital Advisors LLC | 2,333,333 | $43.1M | 0.39% | +923,333+65.5% | Added |
| Point72 Asset Management, L.P. | 2,387,026 | $44.1M | 0.07% | +1,470,884+160.6% | Added |
| Farallon Capital Management, L.L.C. | 2,498,000 | $46.2M | 0.27% | +1,582,000+172.7% | Added |
| State Street Corp | 2,889,287 | $53.4M | 0.00% | +2,817,633+3,932.3% | Added |
| Affinity Asset Advisors, LLC | 2,900,000 | $53.6M | 2.62% | +1,559,160+116.3% | Added |
| TCG Crossover Management, LLC | 3,017,120 | $55.8M | 1.34% | +2,278,737+308.6% | Added |
| Caligan Partners LP | 3,163,866 | $58.5M | 2.82% | +1,528,843+93.5% | Added |
| Deep Track Capital, LP | 3,610,000 | $66.7M | 0.98% | +3,610,000 | New |
| BlackRock, Inc. | 4,365,553 | $80.7M | 0.00% | +4,038,471+1,234.7% | Added |
| FMR LLC | 5,100,216 | $94.3M | 0.00% | +2,220,735+77.1% | Added |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −2,162,684−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −835,484−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −475,165−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −470,775−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −387,982−100.0% | Sold out |
| DV Trading LLC | 0 | $0 | 0.00% | −360,064−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −174,506−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −173,320−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −161,087−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −159,341−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −134,742−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −129,136−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −124,666−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −56,850−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −48,105−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −35,096−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −30,041−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −29,712−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −28,970−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −19,321−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −17,227−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −15,639−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −11,668−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −10,166−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |